Houston Matters
Houston Methodist Studying Effects of Emerging Immunotherapy Drug
Posted on · A study underway at Methodist Hospital compares the effects of an immunotherapy drug to a chemotherapy drug on certain lung cancer development. Lung cancer is the second most common malignancy in the United States. We learn more about the study from its principal investigator, Dr. Eric Bernicker, Thoracic Medical Oncologist with the Houston Methodist Cancer […]